US5474771A
(en)
|
1991-11-15 |
1995-12-12 |
The Trustees Of Columbia University In The City Of New York |
Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
|
US7070777B1
(en)
|
1991-11-15 |
2006-07-04 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting inflammation with an antibody that binds the 5C8 protein
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
US6340459B1
(en)
|
1995-12-01 |
2002-01-22 |
The Trustees Of Columbia University In The City Of New York |
Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients
|
TW517061B
(en)
|
1996-03-29 |
2003-01-11 |
Pharmacia & Amp Upjohn Ab |
Modified/chimeric superantigens and their use
|
US6255455B1
(en)
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
TR200001248T2
(tr)
|
1997-01-10 |
2000-07-21 |
Biogen,Inc. |
Anti-CD40L bileşikleri ile lupus nefritis tedavisi
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
CA2291156A1
(en)
|
1997-05-17 |
1998-11-26 |
Biogen, Inc. |
Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
|
EE9900588A
(et)
|
1997-06-20 |
2000-08-15 |
Biogen, Incorporated |
CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral
|
BR9810755A
(pt)
|
1997-06-20 |
2000-08-15 |
Biogen Inc |
Terapia de bloqueio de cd 154 para a sìndrome inibidora de proteìna terapêutica
|
DE60037822D1
(de)
|
1999-10-22 |
2008-03-06 |
Biogen Idec Inc |
Verwendung eines cd40:cd154 bindungs-unterbrechers zur behandlung immunologischer komplikationen des auges
|
EP1264885A4
(en)
|
2000-02-22 |
2007-02-21 |
Med & Biological Lab Co Ltd |
ANTIBODY LIBRARY
|
GB0019820D0
(en)
|
2000-08-12 |
2000-09-27 |
Koninkl Philips Electronics Nv |
Selective delivery of data
|
FI112501B
(fi)
|
2001-05-18 |
2003-12-15 |
Valtion Teknillinen |
Heveiiniä sitovat monoklonaaliset vasta-aineet
|
EP1396539B1
(en)
|
2001-06-12 |
2008-11-26 |
Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute |
Human-type anti-blood coagulation factor viii antibody
|
EP1439192A1
(en)
|
2003-01-15 |
2004-07-21 |
Xerion Pharmaceuticals AG |
Neuropilin-1 inhibitors
|
GB0315450D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
EP1644507B1
(en)
|
2003-07-03 |
2010-03-17 |
Unicrop Oy |
Novel rubisco promoters and uses thereof
|
CN101031588A
(zh)
|
2004-06-01 |
2007-09-05 |
多曼蒂斯有限公司 |
药物组合物,融合物和结合物
|
KR20120133403A
(ko)
|
2004-06-01 |
2012-12-10 |
도만티스 리미티드 |
증강된 혈청 반감기를 가지는 이특이성 융합 항체
|
RS20070027A
(en)
|
2004-07-26 |
2008-11-28 |
Biogen Idec Ma Inc., |
Anti-cd154 antibodies
|
WO2007011363A2
(en)
|
2004-08-11 |
2007-01-25 |
Trubion Pharmaceuticals, Inc. |
Binding domain fusion proteins
|
RU2007116973A
(ru)
|
2004-10-05 |
2008-11-20 |
Дженентек, Инк. (Us) |
Терапевтические средства с пониженной токсичностью
|
WO2006059110A2
(en)
|
2004-12-02 |
2006-06-08 |
Domantis Limited |
Plad domain peptides with increased serum half life due to conjugation to domain antibodies
|
WO2006098828A2
(en)
|
2005-03-10 |
2006-09-21 |
Matsushita Electric Industrial Co., Ltd. |
Structured diamond tool made by focused ion beam nanomachining
|
WO2006124269A2
(en)
|
2005-05-16 |
2006-11-23 |
Amgen Fremont Inc. |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
JP4940013B2
(ja)
|
2006-07-31 |
2012-05-30 |
富士通株式会社 |
半導体装置に対する同時動作信号ノイズ見積り方法、およびプログラム
|
CL2007002225A1
(es)
|
2006-08-03 |
2008-04-18 |
Astrazeneca Ab |
Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
|
IL199534A
(en)
|
2007-01-05 |
2013-01-31 |
Univ Zuerich |
An isolated human antibody capable of detecting a neoepitope in a disease-related protein, a polynucleotide encoding an antibody, a vector containing the polynucleotide, a host cell containing the polynucleotide or vector, a preparation containing the antibody and related methods and uses.
|
PT2099826E
(pt)
|
2007-01-05 |
2014-01-09 |
Univ Zuerich |
Anticorpo anti-beta-amilóide e suas utilizações
|
JP5721951B2
(ja)
|
2007-03-22 |
2015-05-20 |
バイオジェン アイデック マサチューセッツ インコーポレイテッド |
抗体、抗体誘導体、および抗体断片を含む、cd154に特異的に結合する結合タンパク質ならびにその使用
|
WO2008127655A1
(en)
|
2007-04-13 |
2008-10-23 |
Biogen Idec Ma Inc. |
Anti-alpha 6 beta 4 integrin antibodies and uses therof
|
KR20100021627A
(ko)
|
2007-06-08 |
2010-02-25 |
다우 글로벌 테크놀로지스 인크. |
Ch1 도메인의 절단에 의한 가용성 항체 단편의 발현
|
WO2009002380A2
(en)
|
2007-06-26 |
2008-12-31 |
The Trustees Of The University Of Pennsylvania |
Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
US20110033476A1
(en)
|
2007-11-12 |
2011-02-10 |
Theraclone Sciences Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2009082624A2
(en)
|
2007-12-10 |
2009-07-02 |
Zymogenetics, Inc. |
Antagonists of il-17a, il-17f, and il-23 and methods of using the same
|
EP2604280A3
(en)
|
2008-03-27 |
2013-10-16 |
ZymoGenetics, Inc. |
Compositions and methods for inhibiting PDGFRBETA and VEGF-A
|
CA2721093A1
(en)
|
2008-04-11 |
2009-10-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|
JP2011527338A
(ja)
|
2008-07-09 |
2011-10-27 |
ユニバーシティー オブ チューリッヒ |
神経新生を促進する方法
|
WO2010014854A2
(en)
|
2008-07-31 |
2010-02-04 |
The Regents Of The University Of California |
Antibodies that neutralize botulinum neurotoxins
|
CN102388067A
(zh)
|
2008-09-19 |
2012-03-21 |
米迪缪尼有限公司 |
定向于cd105的抗体及其用途
|
BRPI0918947A2
(pt)
|
2008-09-26 |
2015-12-01 |
Ucb Pharma Sa |
proteína de fusão de anticorpo
|
BRPI0922772B1
(pt)
|
2008-12-05 |
2021-09-08 |
Glaxo Group Limited |
Domínio variável único de imunoglobulina e polipeptídeos isolados
|
US8858948B2
(en)
|
2009-05-20 |
2014-10-14 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
US8841249B2
(en)
|
2009-08-06 |
2014-09-23 |
Novo Nordisk A/S |
Growth hormones with prolonged in-vivo efficacy
|
EP2464383A4
(en)
|
2009-08-14 |
2013-02-13 |
Theraclone Sciences Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU
|
NO2719708T3
(es)
|
2009-11-13 |
2018-03-24 |
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
US20130185821A1
(en)
|
2010-02-08 |
2013-07-18 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
HUE026229T2
(en)
|
2010-02-08 |
2016-06-28 |
Regeneron Pharma |
Common light chain mouse
|
MX339621B
(es)
|
2010-04-13 |
2016-06-02 |
Celldex Therapeutics Inc * |
Anticuerpos que se unen a cd27 humano y uso de los mismos.
|
US20120213771A1
(en)
|
2010-04-13 |
2012-08-23 |
Celldex Therapeutics Inc. |
Antibodies that bind human cd27 and uses thereof
|
EP2601220A2
(en)
|
2010-08-06 |
2013-06-12 |
U3 Pharma GmbH |
Use of her3 binding agents in prostate treatment
|
AU2012205663B2
(en)
|
2011-01-10 |
2017-02-02 |
Emory University |
Antibodies directed against influenza
|
KR20140012098A
(ko)
|
2011-02-14 |
2014-01-29 |
테라클론 사이언시스, 아이엔씨. |
인플루엔자의 치료 및 진단을 위한 조성물 및 방법
|
SG193402A1
(en)
|
2011-03-15 |
2013-10-30 |
Theraclone Sciences Inc |
Compositions and methods for the therapy and diagnosis of influenza
|
AR086360A1
(es)
|
2011-04-21 |
2013-12-11 |
Bristol Myers Squibb Co |
Polipeptidos anticuerpos que antagonizan cd40
|
JOP20200043A1
(ar)
|
2011-05-10 |
2017-06-16 |
Amgen Inc |
طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
|
US8846042B2
(en)
*
|
2011-05-16 |
2014-09-30 |
Fabion Pharmaceuticals, Inc. |
Multi-specific FAB fusion proteins and methods of use
|
PL2718320T3
(pl)
|
2011-06-10 |
2018-06-29 |
Medimmune Limited |
Cząsteczki wiążące przeciwko PSL Pseudomonas i ich zastosowanie
|
EP2739740B1
(en)
|
2011-08-05 |
2019-10-02 |
Regeneron Pharmaceuticals, Inc. |
Humanized universal light chain mice
|
TWI585102B
(zh)
|
2011-10-13 |
2017-06-01 |
必治妥美雅史谷比公司 |
拮抗cd40l之抗體多肽
|
JP5413432B2
(ja)
|
2011-10-20 |
2014-02-12 |
コニカミノルタ株式会社 |
画像形成装置
|
CN104136042B
(zh)
|
2011-11-07 |
2017-08-18 |
米迪缪尼有限公司 |
使用抗假单胞菌Psl和PcrV结合分子的联合治疗
|
CA2865256C
(en)
|
2012-02-23 |
2020-02-11 |
U3 Pharma Gmbh |
Her3 inhibitor for modulating radiosensitivity
|
AU2013204140B2
(en)
|
2012-03-06 |
2016-01-28 |
Regeneron Pharmaceuticals, Inc. |
Common light chain mouse
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
EA039663B1
(ru)
|
2012-05-03 |
2022-02-24 |
Амген Инк. |
Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств
|
KR20220084444A
(ko)
|
2012-05-31 |
2022-06-21 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Pd-l1에 결합하는 항원 결합 단백질
|
EP2855523A4
(en)
|
2012-05-31 |
2016-02-17 |
Sorrento Therapeutics Inc |
ANTIGEN BINDING PROTEINS THAT BIND DLL-4
|
CN104582476B
(zh)
|
2012-06-05 |
2017-03-08 |
瑞泽恩制药公司 |
使用共同轻链制备完全人双特异性抗体的方法
|
JO3462B1
(ar)
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
AU2013341349A1
(en)
|
2012-11-06 |
2015-05-21 |
Medimmune Limited |
Combination therapies using anti-Pseudomonas Psl and PcrV binding molecules
|
CA2903696A1
(en)
|
2013-03-13 |
2014-10-02 |
Regeneron Pharmaceuticals, Inc. |
Common light chain mouse
|
AU2014244020B2
(en)
|
2013-03-13 |
2020-06-04 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
EP2968985A2
(en)
|
2013-03-15 |
2016-01-20 |
Amgen, Inc. |
Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
|
WO2014176128A2
(en)
|
2013-04-22 |
2014-10-30 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
CA2916259C
(en)
|
2013-06-28 |
2024-02-20 |
Amgen Inc. |
Methods for treating homozygous familial hypercholesterolemia
|
TW201920262A
(zh)
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素a之抗體及其用途
|
JP6422977B2
(ja)
|
2013-08-30 |
2018-11-14 |
エイプリルバイオ カンパニー リミテッド |
抗血清アルブミンfabエフェクター部分融合コンストラクト、およびその製造方法
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗pd-l1之人類抗體
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對pd-1的人類抗體
|
KR102351755B1
(ko)
|
2014-04-10 |
2022-01-14 |
다이이찌 산쿄 가부시키가이샤 |
항her3 항체-약물 콘주게이트
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
GB201411320D0
(en)
|
2014-06-25 |
2014-08-06 |
Ucb Biopharma Sprl |
Antibody construct
|
EP3197914B1
(en)
|
2014-09-23 |
2024-02-07 |
Regeneron Pharmaceuticals, Inc. |
Anti-il-25 antibodies and uses thereof
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
MA41459A
(fr)
|
2015-02-03 |
2017-12-12 |
Als Therapy Development Inst |
Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l
|
WO2016135239A1
(en)
*
|
2015-02-25 |
2016-09-01 |
Biotecnol Limited |
Fusion protein comprising three binding domains to her2
|
AU2016232715A1
(en)
|
2015-03-19 |
2017-09-28 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
US11597778B2
(en)
|
2015-04-07 |
2023-03-07 |
The Trustees Of The University Of Pennsylvania |
Human monoclonal autoantibodies to ADAMTS13 and uses thereof
|
EP3297672B1
(en)
*
|
2015-05-21 |
2021-09-01 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
TW201702272A
(zh)
|
2015-05-22 |
2017-01-16 |
美國紀念斯隆 凱特琳癌症中心 |
Prame肽專一性類t細胞受體抗體
|
BR112019000635A2
(pt)
|
2015-07-13 |
2019-04-30 |
Universite Laval |
inibidor de receptor 2 do tipo toll (tlr2) e seu uso, anticorpo, composição e método para tratar uma afecção inflamatória
|
JOP20160154B1
(ar)
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
TW201713690A
(zh)
|
2015-08-07 |
2017-04-16 |
再生元醫藥公司 |
抗angptl8抗體及其用途
|
LT3353212T
(lt)
|
2015-09-23 |
2021-12-27 |
Regeneron Pharmaceuticals, Inc. |
Optimizuoti anti-cd3 bispecifiniai antikūnai ir jų naudojimas
|
US10358497B2
(en)
|
2015-09-29 |
2019-07-23 |
Amgen Inc. |
Methods of treating cardiovascular disease with an ASGR inhibitor
|
TWI756187B
(zh)
|
2015-10-09 |
2022-03-01 |
美商再生元醫藥公司 |
抗lag3抗體及其用途
|
TWI824372B
(zh)
|
2015-10-12 |
2023-12-01 |
美商再生元醫藥公司 |
活化瘦素受體的抗原結合蛋白
|
CR20180365A
(es)
|
2015-12-16 |
2018-09-28 |
Amgen Inc |
PROTEÍNAS DE UNIÓN AL ANTÍGENO BISPECÍFICO DE ANTI-TL1A/ANTI-TNF-a Y SUS USOS
|
GB201522391D0
(en)
*
|
2015-12-18 |
2016-02-03 |
Ucb Biopharma Sprl |
Antibody molecules
|
WO2017189963A1
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
EP3457840B1
(en)
|
2016-05-20 |
2024-04-10 |
Regeneron Pharmaceuticals, Inc. |
Methods for breaking immunological tolerance using multiple guide rnas
|
US10738126B2
(en)
|
2016-06-10 |
2020-08-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-GITR antibodies and uses thereof
|
MY196220A
(en)
|
2016-06-14 |
2023-03-23 |
Regeneron Pharma |
Anti-C5 Antibodies and uses Thereof
|
RU2022104399A
(ru)
|
2016-06-14 |
2022-05-05 |
Ксенкор, Инк. |
Биспецифические антитела-ингибиторы контрольных точек
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
US20180008672A1
(en)
|
2016-07-08 |
2018-01-11 |
Regeneron Pharmaceuticals, Inc. |
Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension
|
CN109476763B
(zh)
|
2016-07-19 |
2023-11-07 |
伊班绰斯有限责任公司 |
双特异性蛋白质及其制备方法
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
WO2018045110A1
(en)
|
2016-08-30 |
2018-03-08 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
EA201990781A9
(ru)
|
2016-09-23 |
2019-11-27 |
|
Анти-steap2 антитела, конъюгаты антитело-лекарственное средство и биспецифические антигенсвязывающие молекулы, которые связывают steap2 и cd3, и их применение
|
US10941208B2
(en)
|
2016-09-23 |
2021-03-09 |
Regeneron Pharmaceuticals, Inc. |
Anti-MUC16 antibodies
|
WO2018075621A1
(en)
|
2016-10-19 |
2018-04-26 |
Vanderbilt University |
Human orthopoxvirus antibodies and methods of use therefor
|
SG10201913470SA
(en)
|
2016-11-08 |
2020-03-30 |
Regeneron Pharma |
Antigen-binding proteins that antagonize leptin receptor
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗met抗體,結合met之雙特異性抗原結合分子及其使用方法
|
MA46842A
(fr)
|
2016-11-17 |
2019-09-25 |
Regeneron Pharma |
Méthodes de traitement de l'obésité au moyen d'anticorps anti-angptl8
|
CA3045466A1
(en)
|
2016-12-01 |
2018-06-07 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
|
WO2018115859A1
(en)
|
2016-12-20 |
2018-06-28 |
Kymab Limited |
Multispecific antibody with combination therapy for immuno-oncology
|
TWI781130B
(zh)
|
2017-01-03 |
2022-10-21 |
美商再生元醫藥公司 |
抗金黃色葡萄球菌溶血素a毒素之人類抗體
|
AU2018219909A1
(en)
|
2017-02-10 |
2019-09-12 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
|
RU2022108410A
(ru)
|
2017-05-24 |
2022-04-05 |
ЭйЭлЭс ТЕРАПИ ДЕВЕЛОПМЕНТ ИНСТИТЬЮТ |
Терапевтические антитела против лиганда cd40
|
WO2019201866A1
(en)
|
2018-04-16 |
2019-10-24 |
Swedish Orphan Biovitrum Ab (Publ) |
Fusion protein
|
KR20210006301A
(ko)
|
2019-07-08 |
2021-01-18 |
주식회사 프로젠 |
신규 융합단백질 및 그의 용도
|